Dr. Geeta Gulati, Department of Cardio Oncology, Oslo University Hospital, Ullevaal, Norway “The difficulty of troponin elevation during treatment with check point inhibitors Monthly Webinars Facebook Twitter Google+ Linkedin Pin It You may also like February 2021 : Optimizing Cancer Survivorship and Cardiovascular outcomes: Gaps and opportunities December 2020 : Cardiac dysfunction in a patient treated with cabozantinib. November 2020: Lung cancer patient with pembrolizumab October 2020 ICOS Monthly Case Study Webinar September 2020 ICOS Monthly Case Study Webinar August 2020 : A case of acute and rapidly progressive RV failure July 2020 Carcinoid Heart Disease secondary to Neuroendocrine Tumors (NET) June 2020: Capecitabine-induced Hypertriglyceridemia: Case Report and Topic Review. May 2020 -“The Promise and Pitfalls of Continuing Trastuzumab in the Presence of Cardiotoxicity” April 2020 Case Review: “Is Oral Chemotherapy Really Safer than IV Chemotherapy? An Osemertinib Cardiotoxicity Case” February 2020 : Special Cardio-Oncology Considerations in Patients with Genetic Syndromes January 2020 : Treating the Treatment: Multi-Organ Toxicities of Fluoropyrimidines and Platinum-based Combination Therapies 123…8»Page 1 of 8
